Evidence map›Paper›PMID 20396900›Full record

ReviewPflugers Archiv : European journal of physiology2010

Channelopathies linked to plasma membrane phosphoinositides.

Diomedes E Logothetis, Vasileios I Petrou, Scott K Adney, Rahul Mahajan

Open access · greenAbstract readReview
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Modulation of the IBBA advances · 2023
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Identification of critical amino acids in the proximal C-terminal of TREK-2 KPflugers Archiv : European journal of physiology · 2018
    Article
  10. Regulation of KCNQ/Kv7 family voltage-gated KBiochimica et biophysica acta. Biomembranes · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Phosphoinositides regulate ion channels.Biochimica et biophysica acta · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Diomedes E LogothetisDepartment of Physiology and Biophysics, Virginia Commonwealth University, School of Medicine, Richmond, VA 23298, USA. delogothetis@vcu.edu
Vasileios I Petrou
Scott K Adney
Rahul Mahajan
Virginia Commonwealth University · USIcahn School of Medicine at Mount Sinai · US

Funding

Structural Determinants of PIP2 RegulationR01HL059949 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Leigh Daniel Plant · 1998 to 2026
$11.6M
Modulation of Kir Channel Function by PhosphorylationR01HL090882 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI LOGOTHETIS, DIOMEDES E. · 2009 to 2012
$1.5M
NHLBI NIH HHS HL059949NHLBI NIH HHS HL090882NHLBI NIH HHS R01 HL059949NHLBI NIH HHS R01 HL090882
6 · The paper itself

Abstract

The plasma membrane phosphoinositide phosphatidylinositol 4,5-bisphosphate (PIP2) controls the activity of most ion channels tested thus far through direct electrostatic interactions. Mutations in channel proteins that change their apparent affinity to PIP2 can lead to channelopathies. Given the fundamental role that membrane phosphoinositides play in regulating channel activity, it is surprising that only a small number of channelopathies have been linked to phosphoinositides. This review proposes that for channels whose activity is PIP2-dependent and for which mutations can lead to channelopathies, the possibility that the mutations alter channel-PIP2 interactions ought to be tested. Similarly, diseases that are linked to disorders of the phosphoinositide pathway result in altered PIP2 levels. In such cases, it is proposed that the possibility for a concomitant dysregulation of channel activity also ought to be tested. The ever-growing list of ion channels whose activity depends on interactions with PIP2 promises to provide a mechanism by which defects on either the channel protein or the phosphoinositide levels can lead to disease.

Indexed as

AnimalsCalcium-Transporting ATPasesChannelopathiesHumansIon ChannelsPhosphatidylinositol 4,5-DiphosphatePotassium Channels, Inwardly RectifyingReceptors, GlutamateReceptors, Purinergic P2Ryanodine Receptor Calcium Release ChannelSodium ChannelsTransient Receptor Potential ChannelsCalcium-Transporting ATPasesIon ChannelsPhosphatidylinositol 4,5-DiphosphatePotassium Channels, Inwardly RectifyingReceptors, GlutamateReceptors, Purinergic P2Ryanodine Receptor Calcium Release ChannelSodium ChannelsTransient Receptor Potential Channels

Identifiers

PMID20396900
PMCPMC4040125
OpenAlexW2093283306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.